SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹303 Cr | ₹348 Cr | ₹322 Cr | ₹320 Cr | ₹191 Cr |
What is the latest Total Current Liabilities ratio of SUVEN PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹303 Cr |
Mar2022 | ₹348 Cr |
Mar2021 | ₹322 Cr |
Mar2020 | ₹320 Cr |
Mar2019 | ₹191 Cr |
How is Total Current Liabilities of SUVEN PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹303 Cr | -12.79 | |
Mar2022 | ₹348 Cr | 8.09 | |
Mar2021 | ₹322 Cr | 0.52 | |
Mar2020 | ₹320 Cr | 67.75 | |
Mar2019 | ₹191 Cr | - |
Compare Total Current Liabilities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹16,439.5 Cr | -0.6% | -0.7% | 35.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -0.6% |
-0.7% |
35.1% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses